Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders
Open accessPublished version of a preprint
The DOI matches its Crossref record; 115 of the 120 references it cites were found in a registry or an index; 45 of the 130 sources its claims cite were checked for support.
Abstract
Peripheral tissue metabolism of steroids (intracrinology) is now accepted as a key way in which tissues, such as the endometrium, can utilise inactive steroids present in the blood to respond to local physiological demands and ‘fine-tune’ the activation or inhibition of steroid hormone receptor-dependent processes. Expression of enzymes that play a critical role in the activation and inactivation of bioactive oestrogens (E1, E2) and androgens (A4, T, DHT), as well as expression of steroid hormone receptors, has been detected in endometrial tissues and cells recovered during the menstrual cycle. There is robust evidence that increased expression of aromatase is important for creating a local microenvironment that can support a pregnancy. Measurement of intra-tissue concentrations of steroids using liquid chromatography–tandem mass spectrometry has been important in advancing our understanding of a role for androgens in the endometrium, acting both as active ligands for the androgen receptor and as substrates for oestrogen biosynthesis. The emergence of intracrinology, associated with disordered expression of key enzymes such as aromatase, in the aetiology of common women’s health disorders such as endometriosis and endometrial cancer has prompted renewed interest in the development of drugs targeting these pathways, opening up new opportunities for targeted therapies and precision medicine.
Overview
CoChat Summary
TL;DR
This review argues that endometrial intracrinology—local activation and inactivation of oestrogens and androgens—is central to normal endometrial function and to disorders such as endometriosis and endometrial cancer. It synthesizes evidence on steroidogenic enzymes, receptor expression, LC-MS/MS tissue steroid measurements, and emerging intracrine-targeted therapies.
Key findings
- Local endometrial steroid concentrations can diverge from serum: LC-MS/MS studies found higher tissue oestrogens than in circulation and increased secretory-phase E2; intra-tissue DHEA was significantly higher than serum in secretory phase, whereas A4 and T were significantly lower in endometrial tissue than serum and not cycle-phase dependent.
- Endometriotic lesions show heterogeneous intracrine steroid production: in proliferative phase, E2 concentrations were approximately 3430 pg/mL in ovarian lesions (endometrioma) versus 238 pg/mL in peritoneal lesions; lesion testosterone exceeded blood, with elevated CYP11A1, CYP17A1 and HSD3B2, lower HSD17B2, and higher HSD17B6 and CYP19A1.
- In endometrial cancer, aromatase and 17βHSD1 expression correlated with poor prognosis; EC tissues had an 8-fold elevation in DHT versus normal endometrium; 5αR1 expression in 65% of samples positively correlated with histological grade, and women immunonegative for both AR and 5αR1 had poorer prognosis.
- Therapeutic targeting is advancing: intravaginal DHEA/prasterone showed local benefit without peripheral serum E2 changes; aromatase inhibitors are considered for postmenopausal endometriosis pain; AKR1C3 inhibitor BAY 1128688 completed phase I in 2016 with phase II underway; 17βHSD1 inhibitor FOR-6219 began phase Ia in July 2018; STS inhibitor STX64/Irosustat did not improve survival in a phase 2 endometrial cancer trial.
Methods
- Narrative review; PubMed and Scopus were searched on 4 May 2018 using terms including intracrinology, endometrium, aromatase, sulfatase and HSD. Reported counts included intracrinology 167 references in Scopus; intracrinology and endometrium 11 PubMed/21 Scopus; aromatase and endometrium 398; aromatase and endometrium and cancer and human 135; sulfatase and endometrium 84; HSD and endometrium 131.
- Evidence was synthesized from human endometrial tissues and cells, mouse models, LC-MS/MS steroid profiling, immunohistochemistry/qRT-PCR, in vitro decidualisation studies, and clinical trial reports; no formal systematic review or meta-analysis is described.
Limitations
- Stated in the paper: whole endometrial tissue homogenates cannot quantify contributions of specific cellular compartments; lesion types differ in local steroid concentrations and steroid-metabolising enzyme expression; no study has identified definitive de novo steroidogenesis from normal endometrial tissue; further studies are needed on cell cross-talk, non-coding RNAs, and therapeutic evaluation.
- Evident from the text: this is a narrative review with a non-systematic search limited to PubMed/Scopus on one date and no formal quality appraisal; many cited therapeutic findings are early-phase, awaited, or from cell/animal models.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Histology of the human endometrium during the normal cycle. Full-thickness endometrial biopsies from hysterectomy specimens stained with haematoxylin and eosin. (A) Proliferative phase: note the presence of long curving glands (G) and some stromal oedema [23]. (B) Secretory phase: note the prominent glands (G), which have a dilated lumen and an irregular outer border stretching down into the basal compartment [24]. In the luminal (functional layer) immune cells are readily detected (most of these are likely to be macrophages and uterine natural killer (uNK) cells [17,19]), as are areas of decidualised fibroblasts (DEC) close to arterioles.](https://figures.cochat.ai/paper-figures/5e773595523641bb91fdbbb026f2a065/endometrial-intracrinology-oestrogens-androgens-and-endometrial-disorders-figure-1.jpg)
![Figure 2 Expression of AKR1C3 in human endometrial stromal fibroblasts is increased in response to a decidualisation stimulus resulting in increased biosynthesis and secretion of testosterone. Based on a figure published in [43] under a CC-BY licence: concentrations of T were determined using an ELISA on days 4 or 8 of the experiment. Immunohistochemistry was determined on day 4 of experiment; AKR1C3 (red stain) Sytox Green nuclear stain (green), no primary antibody negative control (inset) (** p < 0.01).](https://figures.cochat.ai/paper-figures/34497bd770804c58a71cef28219442ed/endometrial-intracrinology-oestrogens-androgens-and-endometrial-disorders-figure-2.jpg)
![Figure 3 In vitro decidualisation of endometrial stromal fibroblasts results in upregulation of aromatase protein expression (green). Based on data reported in [13]. ESC—primary endometrial stromal fibroblasts; positive control (+) was a protein extract from human placenta, aromatase protein 58kDa. Nuclear counterstain DAPI (blue); Aromatase (green); B-Actin loading control (red).](https://figures.cochat.ai/paper-figures/6db870b0750849b3bbc006749bf3b14f/endometrial-intracrinology-oestrogens-androgens-and-endometrial-disorders-figure-3.jpg)
Verification
Claims the paper makes
38 Valid · 0 Not valid · 52 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Detailed immunohistochemical studies using fixed full-thickness endometrial tissues in combination with validated antibodies [27] have identified nuclear staining for AR, ERalpha and ERbeta in the human endometrium during the normal menstrual cycle [16,18,28,29].”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > 2. Endometrium—A Sex Hormone-Dependent Multicellular Tissue > 2.2. Expression of Androgen and Oestrogen Receptors in the Endometrium, Endometriosis and Endometrial Cancer
What the sources say
- Partly supportedcites [27] Saunders, 2000, Differential expression of estrogen receptor-α and -β and androgen receptor in the ovaries of marmosets and humans, Biol. Reprod. sourceExperimental — accuracy not yet measured
The Materials and Methods (pp. 1–2) describe validated receptor antibodies and fixed, paraffin-embedded ovarian tissue from women and marmosets. They do not describe full-thickness endometrial tissue, so the tissue specification attached to this citation is unsupported. The separate citations [16,18,28,29] are offered for the endometrial nuclear-staining finding. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [16] Critchley, 2009, Hormone receptor dynamics in a receptive human endometrium, Reprod. Sci. source
- Not checked — no full text of the sourcecites [18] Henderson, 2003, Steroid receptor expression in uterine natural killer cells, J. Clin. Endocrinol. Metab. source
- Partly supportedcites [28] Marshall, 2011, In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis, J. Clin. Endocrinol. Metab. sourceExperimental — accuracy not yet measured
The Results (page unavailable) report AR immunoexpression in proliferative-phase endometrial stroma, and the Materials and Methods (page unavailable) state that stromal cells express ERα and ERβ. The copy does not establish nuclear staining for all three receptors in fixed full-thickness tissue across the normal menstrual cycle. The validated-antibodies phrase has a separate citation [27], so it is not assessed against this source. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [29] Critchley, 2001, Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium, J. Clin. Endocrinol. Metab. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Landmark studies in mice by the Bagchi group demonstrated that aromatase activity within the endometrium was essential for establishment of pregnancy in that species [49,50].”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > 4. Intracrine Steroid Biosynthesis in the Normal Endometrium > 4.3. Oestrogen Biosynthesis and Metabolism
What the sources say
- Supportedcites [49] Das, 2009, De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis, Proc. Natl. Acad. Sci. USA source
The Results section reports that inhibiting uterine aromatase in pregnant mice severely impaired implantation, reduced decidual mass, and led to resorption of most implanted embryos. The authors conclude that local aromatase activity is essential for endometrial functions supporting early pregnancy; the experiment used ovariectomized, progesterone-supplemented mice. (LLM, conf=0.91)
- Partly supportedcites [50] Das, 2012, Estrogen-induced expression of Fos-related antigen 1 (FRA-1) regulates uterine stromal differentiation and remodeling, J. Biol. Chem. sourceExperimental — accuracy not yet measured
The Discussion (page not provided) says that inhibiting uterine aromatase with letrozole inhibited decidualization and neovascularization in mice, supporting a role for local aromatase activity after embryo attachment. It does not establish that this activity is essential for pregnancy establishment as a whole; the paper distinguishes these post-attachment processes from preimplantation receptivity. (LLM, conf=0.86)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Strikingly, we have demonstrated that conditioned media from decidualised stromal cells increases uNK migration in an oestrogen-dependent manner.”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > 4. Intracrine Steroid Biosynthesis in the Normal Endometrium > 4.5. Intracrine and Paracrine Impact of Tissue Biosynthesis of Androgens and Oestrogens in Endometrium
What the sources say
- Partly supportedcites [57] Gibson, 2015, Estrogen-dependent regulation of human uterine natural killer cells promotes vascular remodelling via secretion of CCL2, Hum. Reprod. sourceExperimental — accuracy not yet measured
The Results section ('Estrogens promote uNK cell motility'; page not provided) reports that direct treatment with E1 or E2 increased uNK migration and that an estrogen-receptor antagonist blocked the effect. The Methods section describes treating isolated uNK cells with estrogens, not conditioned media from decidualised stromal cells. The claimed effect of that conditioned media is therefore not established by this paper. (LLM, conf=0.87)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“There is robust evidence that increased expression of aromatase is important for creating a local microenvironment that can support a pregnancy.”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > Abstract
What the sources say
- Supportedcites [49] Das, 2009, De novo synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis, Proc. Natl. Acad. Sci. USA source
The Results report increased aromatase expression in the decidua during early mouse pregnancy and show that inhibiting its activity impaired implantation and embryo development. The Discussion explains that locally produced estrogen promotes vascular development in the decidual tissue, supporting the claimed pregnancy-supportive local environment. (LLM, conf=0.90)
- Supportedcites [50] Das, 2012, Estrogen-induced expression of Fos-related antigen 1 (FRA-1) regulates uterine stromal differentiation and remodeling, J. Biol. Chem. source
The Discussion reports increased uterine P450 aromatase during early pregnancy in mice and says that blocking its activity inhibited decidualization and neovascularization. These findings support the claim that increased aromatase helps create a local uterine environment supportive of pregnancy, within the mouse setting studied. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Peripheral tissue metabolism of steroids (intracrinology) is now accepted as a key way in which tissues, such as the endometrium, can utilise inactive steroids present in the blood to respond to local physiological demands and ‘fine-tune’ the activation or inhibition of steroid hormone receptor-dependent processes.”
- Also stated in: § 1. What Do We Mean by ‘Intracrinology’? · plain
“Peripheral tissue metabolism of steroids is now accepted as a key way in which tissues such as the endometrium can respond to local physiological demands and ‘fine-tune’ the activation or inhibition of steroid hormone receptor-dependent processes.”
§ Endometrial Intracrinology: Oestrogens, Androgens and Endometrial Disorders > Abstract
What the sources say
- Not checked — no full text of the sourcecites [3] Huhtinen, 2014, Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions, J. Clin. Endocrinol. Metab. source
- Not checked — no full text of the sourcecites [4] Huhtinen, 2012, Estrogen biosynthesis and signaling in endometriosis, Mol. Cell. Endocrinol. source
- Not checked — no full text of the sourcecites [5] Labrie, 2001, DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology, Front. Neuroendocrinol. source
- Supportedcites [6] Labrie, 2000, Intracrinology: Role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease, J. Mol. Endocrinol. source
The Abstract describes circulating inactive precursors being converted to active sex steroids in peripheral tissues and says those tissues adjust steroid formation and metabolism to local requirements. The section on 17-HSDs identifies the endometrium among human tissues with high estrogen-forming enzyme activity. Together, these passages support the sentence’s description of local fine-tuning of steroid action; page numbers are not available in our copy. (LLM, conf=0.88)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 1. What Do We Mean by ‘Intracrinology’? · plain
65 more claims · 17 with their cited sources checked
Create a free account to see all 101 claims and to verify the 9 references still open.
- It may state two separate claims as one. 31
Citations
Cites
Noyes, R. W., Hertig, A. T., & Rock, J. (1950) · Fertility and Sterility · doi:10.1016/s0015-0282(16)30062-0 · Cited by 2,843 · cited 1×
“(A) Proliferative phase: note the presence of long curving glands (G) and some stromal oedema [23].”
BackgroundEndometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940 · cited 2×
“Endometriosis can be associated with debilitating pelvic pain and in most but not all women, symptoms regress after menopause, with many of the drug regimens used to treat symptomatic endometriosis being based on suppression of ovarian cyclicity [64].”
BackgroundNatural killer cells and pregnancy
Moffett-King, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri886 · Cited by 1,235
Dupont, S., Krust, A., Gansmuller, A., Dierich, A., Chambon, P., & Mark, M. (2000) · Development · doi:10.1242/dev.127.19.4277 · Cited by 1,064
Burger, H. G. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)02985-0 · Cited by 771 · cited 16×
“DHEA is produced by the adrenal glands and by the ovary and is abundant in the circulation.”
BackgroundInfluentialLabrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
The Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419 · cited 1×
“Sulfation is mediated by sulfotransferase enzymes and requires the action of 3′-phospho-adenosine-5′-phosphosulphate synthase (PAPSS) enzymes to provide a sulphate moiety for conjugation [53].”
BackgroundDalton, J. T., Barnette, K. G., Bohl, C. E., Hancock, M. L., Rodriguez, D., Dodson, S. T., Morton, R. A., & Steiner, M. S. (2011) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0034-6 · Cited by 403 · cited 1×
“The pharmaceutical industries have developed a number of selective androgen receptor modulators to target AR in muscle as a therapy for age-related or cancer-related loss of muscle function [91,92].”
BackgroundLabrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366 · cited 1×
“However, in more recent studies and reviews, ‘intracrinology’ is now usually discussed on the basis that it is tissue-specific, local production (and inactivation) of sex steroids without significant release of active sex steroids into the peripheral circulation [1,5,6], with less attention being paid to the source an…”
BackgroundMenstrual physiology: implications for endometrial pathology and beyond
Maybin, J. A., & Critchley, H. O. D. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv038 · Cited by 337 · cited 1×
“It is notable that many authors have classified menstruation as an ‘inflammatory event’ highlighting increased concentrations of prostaglandins, which may also be generated by intracrine mechanisms, involving local enzyme expression, as well as increased synthesis of pro-inflammatory cytokines, chemokines and matrix m…”
BackgroundNew concepts for an old problem: the diagnosis of endometrial hyperplasia
Sanderson, P. A., Critchley, H. O. D., Williams, A. R. W., Arends, M. J., & Saunders, P. T. K. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw042 · Cited by 323 · cited 1×
“Established risk factors for development of EC include obesity and the presence of premalignant lesions associated with endometrial hyperplasia [75,76], with oestrogen exposure considered a key driver of both endometrial hyperplasia and Type I EC that make up 75% of EC cases [76].”
BackgroundSelf-citationBody mass index, hormone replacement therapy, and endometrial cancer risk: A meta-analysis
Crosbie, E. J., Zwahlen, M., Kitchener, H. C., Egger, M., & Renehan, A. G. (2010) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0832 · Cited by 321 · cited 1×
“Established risk factors for development of EC include obesity and the presence of premalignant lesions associated with endometrial hyperplasia [75,76], with oestrogen exposure considered a key driver of both endometrial hyperplasia and Type I EC that make up 75% of EC cases [76].”
BackgroundRole of Estrogen Receptor-β in Endometriosis
Bulun, S., Monsavais, D., Pavone, M., Dyson, M., Xue, Q., Attar, E., Tokunaga, H., & Su, E. (2012) · Seminars in Reproductive Medicine · doi:10.1055/s-0031-1299596 · Cited by 321 · cited 1×
“Examples include epithelial cell expression of AR in endometrial cancers [26] and upregulation of ERbeta in endometriosis [35].”
BackgroundProstaglandin E2 Stimulates Aromatase Expression in Endometriosis-Derived Stromal Cells
Noble, L. S. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.600 · Cited by 301
Reprint of: Dating the Endometrial Biopsy
Noyes, R. W., Hertig, A. T., & Rock, J. (2019) · Fertility and Sterility · doi:10.1016/j.fertnstert.2019.08.079 · Cited by 301
Steroid receptor expression in uterine natural killer cells
Henderson, T. A., Saunders, P. T. K., Moffett-King, A., Groome, N. P., & Critchley, H. O. D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021174 · Cited by 283 · cited 7×
“Examples include epithelial cell expression of AR in endometrial cancers [26] and upregulation of ERbeta in endometriosis [35].”
BackgroundInfluentialSelf-citationLabrie, F., Luu-The, V, Lin, S., Simard, J., Labrie, C., El-Alfy, M., Pelletier, G., & Belanger, A. (2000) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0250001 · Cited by 278 · cited 1×
“However, in more recent studies and reviews, ‘intracrinology’ is now usually discussed on the basis that it is tissue-specific, local production (and inactivation) of sex steroids without significant release of active sex steroids into the peripheral circulation [1,5,6], with less attention being paid to the source an…”
BackgroundEndometriosis: an overview of Cochrane Reviews
Brown, J., & Farquhar, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009590.pub2 · Cited by 270 · cited 1×
“A recent Cochrane review concluded that, ‘for women with pain and endometriosis, suppression of menstrual cycles with gonadotrophin-releasing hormone (GnRH) analogues, the levonorgestrel-releasing intrauterine system (LNG-IUD) or Danazol were beneficial interventions’ [67].”
BackgroundAromatase and other steroidogenic genes in endometriosis: translational aspects.
Attar, E., & Bulun, S. E. (2006) · Human Reproduction Update · doi:10.1093/humupd/dmi034 · Cited by 255 · cited 2×
“Local oestrogen production, accompanied by intracrine and paracrine signalling via ERbeta in endometriotic tissues is believed to contribute to a feed-forward signalling cascade that maintains an inflammatory state and cell proliferation within the endometriotic lesions (for a comprehensive review on the role of oestr…”
BackgroundInflammation, leukocytes and menstruation
Evans, J., & Salamonsen, L. A. (2012) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9223-7 · Cited by 252 · cited 1×
“It is notable that many authors have classified menstruation as an ‘inflammatory event’ highlighting increased concentrations of prostaglandins, which may also be generated by intracrine mechanisms, involving local enzyme expression, as well as increased synthesis of pro-inflammatory cytokines, chemokines and matrix m…”
BackgroundRothman, M. S., Carlson, N. E., Xu, M., Wang, C., Swerdloff, R., Lee, P., Goh, V. H. H., Ridgway, E. C., & Wierman, M. E. (2011) · Steroids · doi:10.1016/j.steroids.2010.10.010 · Cited by 248 · cited 1×
“These studies are of particular relevance to the impact of aging on fertility, as circulating concentrations of androgens precursors, such as DHEA and A4 as well as T and DHT decline with age [38,63].”
BackgroundIntracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217 · cited 1×
“For example, in their recent comprehensive review of intracrine androgen biosynthesis and metabolism, Schiffer and colleagues highlighted the importance of peripheral metabolism of steroids in metabolic target tissues including adipose and skeletal muscle [88].”
BackgroundO’Reilly, M. W., Kempegowda, P., Walsh, M., Taylor, A. E., Manolopoulos, K. N., Allwood, J. W., Semple, R. K., Hebenstreit, D., Dunn, W. B., Tomlinson, J. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00947 · Cited by 215 · cited 1×
“Insulin stimulates AKR1C3 expression in the adipose tissue of women with PCOS and its inhibition has been suggested as offering a therapeutic target to reduce the hyperandrogenism that is a feature of this disorder [101].”
BackgroundEndometriosis: clinical features, MR imaging findings and pathologic correlation
Foti, P. V., Farina, R., Palmucci, S., Vizzini, I. A. A., Libertini, N., Coronella, M., Spadola, S., Caltabiano, R., Iraci, M., Basile, A., et al. (2018) · Insights into Imaging · doi:10.1007/s13244-017-0591-0 · Cited by 214 · cited 1×
“A recent review provides an excellent overview of the features of endometriosis as determined by magnetic resonance imaging [65].”
BackgroundCritchley, H. O. D., Brenner, R. M., Henderson, T. A., Williams, K., Nayak, N. R., Slayden, O. D., Millar, M. R., & Saunders, P. T. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7317 · Cited by 210
Self-citationAttar, E., Tokunaga, H., Imir, G., Yilmaz, M. B., Redwine, D., Putman, M., Gurates, B., Attar, R., Yaegashi, N., Hales, D. B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1180 · Cited by 207 · cited 1×
“role in the steroidogenic enzyme machinery, including STAR, 17-hydroxylase/17,20-lyase, 3β-HSD and aromatase, which may be consistent with the synthesis of E2 from cholesterol within lesions [72,74].”
BackgroundEstradiol is a critical mediator of macrophage-nerve cross talk in peritoneal endometriosis
Greaves, E., Temp, J., Esnal-Zufiurre, A., Mechsner, S., Horne, A. W., & Saunders, P. T. K. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.04.012 · Cited by 201 · cited 1×
“In common with other immune cells found in the endometrium (macrophages, mast cells [55,56]), uNK cells express ERbeta [18].”
BackgroundSelf-citationDubois, V., Laurent, M., Boonen, S., Vanderschueren, D., & Claessens, F. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0883-3 · Cited by 197 · cited 1×
“Studies on the role of AR in skeletal muscle conducted using transgenic mouse models have shown it is expressed in multiple cell types in muscle [89,90].”
BackgroundAromatase: biologic relevance of tissue-specific expression
(2004) · Seminars in Reproductive Medicine · doi:10.1055/s-2004-823023 · Cited by 190 · cited 1×
“Expression of the CYP19A1 gene is regulated by tissue-specific promoters, distributed over a 93kb regulatory region, which have been the subject of extensive investigation [78].”
BackgroundCyclooxygenase enzymes and prostaglandins in pathology of the endometrium
Sales, K. J., & Jabbour, H. N. (2003) · Reproduction · doi:10.1530/rep.0.1260559 · Cited by 177 · cited 1×
“3/II promoter region, which can be upregulated by prostaglandins such as PGE2, providing a link between the overexpression of PGs that has been reported to occur in EC [79] and intracrine oestrogen biosynthesis [80].”
BackgroundSaunders, P. T. K., Millar, M. R., Williams, K., Macpherson, S., Harkiss, D., Anderson, R. A., Orr, B., Groome, N. P., Scobie, G., & Fraser, H. M. (2000) · Biology of Reproduction · doi:10.1095/biolreprod63.4.1098 · Cited by 175 · cited 1×
“Detailed immunohistochemical studies using fixed full-thickness endometrial tissues in combination with validated antibodies [27] have identified nuclear staining for AR, ERalpha and ERbeta in the human endometrium during the normal menstrual cycle [16,18,28,29].”
BackgroundSelf-citationCloke, B., Huhtinen, K., Fusi, L., Kajihara, T., Yliheikkilä, M., Ho, K.-K., Teklenburg, G., Lavery, S., Jones, M. C., Trew, G., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0356 · Cited by 159 · cited 1×
“[60,61], who showed that AR and PR regulated distinct genomic pathways during decidualisation, consistent with a role for androgens (either local or peripheral) in regulation of fertility.”
BackgroundIL-1, IL-6 and TNF-alpha concentrations in the peritoneal fluid of women with pelvic adhesions
Cheong, Y. C. (2002) · Human Reproduction · doi:10.1093/humrep/17.1.69 · Cited by 159
Estrogen metabolism and action in endometriosis
Rižner, T. L. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.022 · Cited by 153 · cited 1×
“There has also been a rapid increase in the number of studies considering the role of locally produced (intracrine) steroids in the aetiology of pathologies including cancers of the breast [8,9] and endometrium [10–12], as well as in regulation of fertility [13] and the aetiology of the oestrogen-dependent disorder en…”
BackgroundEstrogen metabolizing enzymes in endometrium and endometriosis
Dassen, H., Punyadeera, C., Kamps, R., Delvoux, B., Van Langendonckt, A., Donnez, J., Husen, B., Thole, H., Dunselman, G., & Groothuis, P. (2007) · Human Reproduction · doi:10.1093/humrep/dem310 · Cited by 141 · cited 1×
“STS is expressed in normal endometrial tissues and in endometrial cancers [51,52].”
BackgroundThe importance of the macrophage within the human endometrium
Thiruchelvam, U., Dransfield, I., Saunders, P. T. K., & Critchley, H. O. D. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0712327 · Cited by 140 · cited 2×
“In the luminal (functional layer) immune cells are readily detected (most of these are likely to be macrophages and uterine natural killer (uNK) cells [17,19]), as are areas of decidualised fibroblasts (DEC) close to arterioles.”
BackgroundSelf-citationAromatase inhibitors for the treatment of endometriosis
Pavone, M. E., & Bulun, S. E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.053 · Cited by 138 · cited 2×
“These have been complemented by several studies reporting on the positive impact, or lack thereof, of aromatase inhibitors (AI) including letrozole and anastrozole on symptoms of endometriosis in both pre- and post-menopausal women [99,100].”
BackgroundHormone receptor dynamics in a receptive human endometrium
Critchley, H. O. D., & Saunders, P. T. K. (2009) · Reproductive Sciences · doi:10.1177/1933719108331121 · Cited by 133 · cited 2×
“Detailed immunohistochemical studies using fixed full-thickness endometrial tissues in combination with validated antibodies [27] have identified nuclear staining for AR, ERalpha and ERbeta in the human endometrium during the normal menstrual cycle [16,18,28,29].”
BackgroundSelf-citationDas, A., Mantena, S. R., Kannan, A., Evans, D. B., Bagchi, M. K., & Bagchi, I. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901647106 · Cited by 131 · cited 3×
“In summary, the evidence presented in the studies described above, together with those in mice [49], all support the hypothesis that tight temporal-spatial regulation of tissue function by intracrine oestrogens plays a previously underappreciated role in modulating the function of cells (endothelial, uNK, decidual fib…”
BackgroundResultSteroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
Purohit, A., & Foster, P. A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0266 · Cited by 126 · cited 1×
“Several potent STS inhibitors have been developed [107], including STX64, which was effective in blocking synthesis in endometrial cancer cells in vitro.”
BackgroundDubois, V., Laurent, M. R., Sinnesael, M., Cielen, N., Helsen, C., Clinckemalie, L., Spans, L., Gayan‐Ramirez, G., Deldicque, L., Hespel, P., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-249748 · Cited by 124 · cited 1×
“Studies on the role of AR in skeletal muscle conducted using transgenic mouse models have shown it is expressed in multiple cell types in muscle [89,90].”
BackgroundDevelopment and validation of a new monoclonal antibody to mammalian aromatase
Turner, K., Macpherson, S., Millar, M., McNeilly, A., Williams, K., Cranfield, M., Groome, N., Sharpe, R., Fraser, H., & Saunders, P. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1720021 · Cited by 123 · cited 1×
“Notably, ERalpha is present in the epithelial cells lining the glands and lumen during the proliferative phase, at a time when circulating oestrogens are rising rapidly due to growth of antral follicles containing granulosa cells expressing aromatase [31], but is downregulated during the secretory phase [29].”
BackgroundSelf-citationCritchley, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1370 · Cited by 114
Molecular biology of endometriosis: from aromatase to genomic abnormalities
Monsivais, D., Kakinuma, T., Furukawa, Y., Bernardi, L., Pavone, M., Dyson, M., & Bulun, S. (2015) · Seminars in Reproductive Medicine · doi:10.1055/s-0035-1554053 · Cited by 112 · cited 1×
“Whilst our literature search terms ‘intracrine and endometriosis’ only identified five papers on PUBMED it is notable that the alternative search ‘aromatase and endometriosis’ identified more than 300, reflecting widespread interest in the role of local (intracrine) biosynthesis in the aetiology of this complex disord…”
BackgroundNon-Coding RNAs in Endometrial Physiopathology
Ferlita, A. L., Battaglia, R., Andronico, F., Caruso, S., Cianci, A., Purrello, M., & Pietro, C. D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072120 · Cited by 108
Gibson, D. A., Greaves, E., Critchley, H. O. D., & Saunders, P. T. K. (2015) · Human Reproduction · doi:10.1093/humrep/dev067 · Cited by 108 · cited 1×
“In addition, treatment of uNK cells with E2 resulted in increased secretion of angiogenic factors, including CCL2, which had a significant impact on endometrial endothelial cell network formation [57].”
BackgroundSelf-citationEstrogen biosynthesis and signaling in endometriosis
Huhtinen, K., Ståhle, M., Perheentupa, A., & Poutanen, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.08.022 · Cited by 107 · cited 7×
“In addition to AKR1C3 (also known as HSD17B5), HSD17B7 and 12 are reported to have reductive 17β-HSD activity, mediating conversion of A4 to T, and mRNA expression of HSD17B7 and HSD17B12 has been reported in total tissue homogenates of normal human endometrium but with no significant cycle-dependent change in express…”
BackgroundMethodInfluentialDay, J. M., Foster, P. A., Tutill, H. J., Parsons, M. F. C., Newman, S. P., Chander, S. K., Allan, G. M., Lawrence, H. R., Vicker, N., Potter, B. V. L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23350 · Cited by 107
Androgens and endometrium: new insights and new targets
Simitsidellis, I., Saunders, P. T. K., & Gibson, D. A. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.09.022 · Cited by 107 · cited 2×
“Taken together, these studies suggest both local activation and metabolism of androgens occur during decidualisation and that temporal regulation of intracrine androgen bioavailability is a critical mediator of endometrial competence during remodelling required for establishment of pregnancy [39,59].”
BackgroundSelf-citationGibson, D. A., & Saunders, P. T. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.026 · Cited by 107 · cited 2×
“These receptors may act within the nucleus as ligand-activated transcription factors by several different mechanisms: (1) binding directly to hormone ‘responsive elements’ on target genes for example DNA sequences shown to have specificity for the androgen receptor (androgen response element, ARE) or either of the oes…”
BackgroundSelf-citationWilkens, J., Male, V., Ghazal, P., Forster, T., Gibson, D. A., Williams, A. R. W., Brito-Mutunayagam, S. L., Craigon, M., Lourenco, P., Cameron, I. T., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300958 · Cited by 101 · cited 1×
“In the luminal (functional layer) immune cells are readily detected (most of these are likely to be macrophages and uterine natural killer (uNK) cells [17,19]), as are areas of decidualised fibroblasts (DEC) close to arterioles.”
BackgroundSelf-citationThe important roles of steroid sulfatase and sulfotransferases in gynecological diseases
Rižner, T. L. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00030 · Cited by 98
Labrie, F., Martel, C., Bélanger, A., & Pelletier, G. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.007 · Cited by 95 · cited 1×
“In this regard, a strong case has been made that the ‘inactive’ adrenal steroid dehydroepiandrosterone (DHEA) is the most important precursor of bioactive androgens in women [7].”
BackgroundStructural changes in endometrial basal glands during menstruation
Garry, R., Hart, R., Karthigasu, K., & Burke, C. (2010) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2010.02630.x · Cited by 94 · cited 2×
“(B) Secretory phase: note the prominent glands (G), which have a dilated lumen and an irregular outer border stretching down into the basal co partment [24].”
BackgroundDalton, J. T., Taylor, R. P., Mohler, M. L., & Steiner, M. S. (2013) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0000000000000015 · Cited by 91 · cited 1×
“The pharmaceutical industries have developed a number of selective androgen receptor modulators to target AR in muscle as a therapy for age-related or cancer-related loss of muscle function [91,92].”
BackgroundRubin, G. L. (1999) · Molecular Human Reproduction · doi:10.1093/molehr/5.11.995 · Cited by 88 · cited 1×
“The main oestrogen sulphotransferase (SULT1E1) is expressed in endometrial epithelial cells and expression is increased in response to progesterone [54] highlighting a potentially complex balance between activation and inactivation of steroids during the fertile phase of the cycle that may involve more than one cell t…”
BackgroundCritchley, H. O. D., Henderson, T. A., Kelly, R. W., Scobie, G. S., Evans, L. R., Groome, N. P., & Saunders, P. T. K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020502 · Cited by 87
Self-citationAromatase excess in cancers of breast, endometrium and ovary
Bulun, S. E., Chen, D., Lu, M., Zhao, H., Cheng, Y., Demura, M., Yilmaz, B., Martin, R., Utsunomiya, H., Thung, S., et al. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.027 · Cited by 85 · cited 1×
“3/II promoter region, which can be upregulated by prostaglandins such as PGE2, providing a link between the overexpression of PGs that has been reported to occur in EC [79] and intracrine oestrogen biosynthesis [80].”
BackgroundSteroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma
Utsunomiya, H., Ito, K., Suzuki, T., Kitamura, T., Kaneko, C., Nakata, T., Niikura, H., Okamura, K., Yaegashi, N., & Sasano, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0040 · Cited by 85
Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer
Rižner, T. L. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.07.026 · Cited by 85
Kamal, A. M., Bulmer, J. N., DeCruze, S. B., Stringfellow, H. F., Martin-Hirsch, P., & Hapangama, D. K. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.16 · Cited by 84 · cited 1×
“[86] reported that the expression of AR was downregulated in high-grade EC but elevated in metastases, raising the possibility that they might be a target for therapy.”
BackgroundMustonen, M. V. J., Isomaa, V. V., Vaskivuo, T., Tapanainen, J., Poutanen, M. H., Stenbäck, F., Vihko, R. K., & Vihko, P. T. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4709 · Cited by 84 · cited 1×
“Expression of HSD17B2 is increased by progesterone and elevated in the secretory phase [4,45].”
BackgroundRegulation of aromatase expression in breast cancer tissue
Bulun, S. E., Lin, Z., Zhao, H., Lu, M., Amin, S., Reierstad, S., & Chen, D. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.03705.x · Cited by 83 · cited 1×
“Examination of ectopic lesions revealed that they are characterised by high aromatase expression levels, together with a deficiency in 17β-HSD2, the enzyme responsible for the inactivation of E2 to E1 [66].”
BackgroundGibson, D. A., Simitsidellis, I., Cousins, F. L., Critchley, H. O. D., & Saunders, P. T. K. (2016) · Scientific Reports · doi:10.1038/srep19970 · Cited by 82 · cited 10×
“Based on a figure p blished in [43] under a CC-BY licence: concentrations of T were determined using an ELISA o days 4 or 8 of the experiment.”
BackgroundMethodInfluentialSelf-citationThe intracrinology of breast cancer
McNamara, K. M., & Sasano, H. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.04.004 · Cited by 78 · cited 1×
“There has also been a rapid increase in the number of studies considering the role of locally produced (intracrine) steroids in the aetiology of pathologies including cancers of the breast [8,9] and endometrium [10–12], as well as in regulation of fertility [13] and the aetiology of the oestrogen-dependent disorder en…”
BackgroundThe role of androgens and the androgen receptor in cycling endometrium
Cloke, B., & Christian, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.031 · Cited by 77 · cited 1×
“[60,61], who showed that AR and PR regulated distinct genomic pathways during decidualisation, consistent with a role for androgens (either local or peripheral) in regulation of fertility.”
BackgroundYang, S., Fang, Z., Suzuki, T., Sasano, H., Zhou, J., Gurates, B., Tamura, M., Ferrer, K., & Bulun, S. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8486 · Cited by 77 · cited 1×
“For example, there are a number of reports that aromatase is expressed in endometriosis lesions with evidence of a positive feed-forward loop involving local biosynthesis of both E2 and the pro-inflammatory regulator prostaglandin E2 [69,98].”
BackgroundWhitaker, L. H. R., Murray, A. A., Matthews, R., Shaw, G., Williams, A. R. W., Saunders, P. T. K., & Critchley, H. O. D. (2017) · Human Reproduction · doi:10.1093/humrep/dew359 · Cited by 77 · cited 2×
“withdrawal with demise of the corpus luteum) [28] or in response to administration of progesterone receptor antagonists/selective modulators [30].”
BackgroundSelf-citationHuhtinen, K., Saloniemi-Heinonen, T., Keski-Rahkonen, P., Desai, R., Laajala, D., Ståhle, M., Häkkinen, M. R., Awosanya, M., Suvitie, P., Kujari, H., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1913 · Cited by 75 · cited 8×
“In contrast, they found that concentrations of androstenedione (A4) and T were significantly lower in endometrial tissue homogenates than in the serum and that these were not cycle phase-dependent [3].”
BackgroundMethodResultInfluentialPGE2 and PGF2α release by human peritoneal macrophages in endometriosis
Karck, U., Reister, F., Schdfer, W., Zahradnik, H.-P., & Breckwoldt, M. (1996) · Prostaglandins · doi:10.1016/0090-6980(95)00159-x · Cited by 75 · cited 1×
“Peritoneal fluid from women with endometriosis contains high concentrations of pro-inflammatory cytokines, such as TNFα and IL-1β [70,71], which have the capacity to stimulate expression of the prostaglandin synthesis enzyme COX-2 and increase secretion of prostaglandin E2 (PGE2) by endometriotic cells and peritoneal…”
BackgroundEvidence of androgen action in endometrial and ovarian cancers
Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0551 · Cited by 73
Self-citationPotter, B. V. L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0045 · Cited by 73
Martel, C., Labrie, F., Archer, D. F., Ke, Y., Gonthier, R., Simard, J.-N., Lavoie, L., Vaillancourt, M., Montesino, M., Balser, J., et al. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.016 · Cited by 72 · cited 1×
“They have demonstrated positive impacts on vaginal dryness and other steroid hormone-dependent parameters without any evidence of peripheral changes in serum E2 [94,95].”
BackgroundRé, R. N. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)90772-4 · Cited by 70 · cited 1×
“The term ‘intracrine’ emerged in the 1980s as a new concept in endocrinology based on the ability of cells within non-gonadal tissues to both produce (synthesise) a hormone (peptide, protein or steroid) and to respond to that same factor [1,2].”
BackgroundWinuthayanon, W., Lierz, S. L., Delarosa, K. C., Sampels, S. R., Donoghue, L. J., Hewitt, S. C., & Korach, K. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07728-1 · Cited by 67 · cited 1×
“Uterine epithelial ERalpha is dispensable for proliferation but essential for complete biological and biochemical responses; [32].”
BackgroundMarshall, E., Lowrey, J., MacPherson, S., Maybin, J. A., Collins, F., Critchley, H. O. D., & Saunders, P. T. K. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0272 · Cited by 66
Self-citationCatalano, R. D., Wilson, M. R., Boddy, S. C., & Jabbour, H. N. (2011) · Molecular Human Reproduction · doi:10.1093/molehr/gaq094 · Cited by 62 · cited 1×
“demonstrated that AKR1C3 expression is increased in the secretory phase relative to proliferative phase with peak expression reported in the early- to mid-secretory phase [42].”
BackgroundLabrie, F., Archer, D. F., Bouchard, C., Girard, G., Ayotte, N. J., Gallagher, J. C., Cusan, L., Baron, M., Blouin, F., Waldbaum, A. S., et al. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.02.005 · Cited by 61 · cited 1×
“Labrie and colleagues have conducted several studies and clinical trials to analyse the impact of intravaginal administration of DHEA (Prasterone; brand name in USA Intrarosa) on adverse symptoms resulting from postmenopausal steroid deprivation including vaginal atrophy and pain during sexual intercourse [93].”
BackgroundDelvoux, B., D'Hooghe, T., Kyama, C., Koskimies, P., Hermans, R. J. J., Dunselman, G. A., & Romano, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2851 · Cited by 59
Utsunomiya, H., Suzuki, T., Kaneko, C., Takeyama, J., Nakamura, J., Kimura, K., Yoshihama, M., Harada, N., Ito, K., Konno, R., et al. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7661 · Cited by 57 · cited 1×
“Sasano and collaborators have developed novel antibodies and reported evidence of increased immunoexpression of aromatase [81], STS [82] and 17βHSD enzymes [83] in endometrial hyperplasia and EC.”
Background17β-hydroxysteroid dehydrogenases in human endometrium and its disorders
Ito, K., Utsunomiya, H., Suzuki, T., Saitou, S., Akahira, J.-I., Okamura, K., Yaegashi, N., & Sasano, H. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.038 · Cited by 54 · cited 1×
“Expression of several 17β-hydroxysteroid dehydrogenase (HSD17B) isozymes have been reported in endometrial tissues/cells [44].”
BackgroundSegawa, T., Shozu, M., Murakami, K., Kasai, T., Shinohara, K., Nomura, K., Ohno, S., & Inoue, M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1859 · Cited by 52 · cited 1×
“Notably, expression of aromatase and 17βHSD 1 in EC have both been correlated with poor prognosis [84,85].”
BackgroundDehydroepiandrosterone enhances decidualization in women of advanced reproductive age
Gibson, D. A., Simitsidellis, I., Kelepouri, O., Critchley, H. O. D., & Saunders, P. T. K. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.12.024 · Cited by 51 · cited 3×
“Thus there is the potential that administration of DHEA during the secretory phase alone may also assist fertility in older women, although this clearly requires further evaluation [40].”
BackgroundSelf-citationCaruso, S., Cianci, S., Vitale, S. G., Matarazzo, M. G., Amore, F. F., & Cianci, A. (2017) · Menopause · doi:10.1097/gme.0000000000000851 · Cited by 50 · cited 1×
“In other studies, significant benefit for vaginal health has been demonstrated using estriol gel [96]: these data have collectively provided powerful evidence for intracrine steroid modulation playing a key role in regulation of the vaginal microenvironment, which can be harnessed for therapeutic benefit after ovarian…”
BackgroundLabrie, F. (2019) · Menopause · doi:10.1097/gme.0000000000001177 · Cited by 50 · cited 1×
“In other studies, significant benefit for vaginal health has been demonstrated using estriol gel [96]: these data have collectively provided powerful evidence for intracrine steroid modulation playing a key role in regulation of the vaginal microenvironment, which can be harnessed for therapeutic benefit after ovarian…”
BackgroundKeski‐Rahkonen, P., Huhtinen, K., Desai, R., Tim Harwood, D., Handelsman, D. J., Poutanen, M., & Auriola, S. (2013) · Journal of Mass Spectrometry · doi:10.1002/jms.3252 · Cited by 47 · cited 1×
“Strikingly, they found that concentrations of oestrogens were higher in endometrial tissue than in the circulation and that concentrations of E2 were increased in secretory phase compared to proliferative phase tissues [3,37], with the latter finding being consistent with increased expression of enzymes such as aromat…”
BackgroundPiccinato, C. A., Neme, R. M., Torres, N., Sanches, L. R., Derogis, P. B. M. C., Brudniewski, H. F., Rosa e Silva, J. C., & Ferriani, R. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.12.025 · Cited by 45 · cited 1×
“The evidence that STS is expressed in endometrial cancers [52,105] and endometriosis [106] has prompted the development of specific STS inhibitors as novel therapies.”
BackgroundInhibition of steroid sulfatase decreases endometriosis in an in vivo murine model
Colette, S., Defrere, S., Lousse, J. C., Van Langendonckt, A., Gotteland, J. P., Loumaye, E., & Donnez, J. (2011) · Human Reproduction · doi:10.1093/humrep/der079 · Cited by 45 · cited 1×
“Another inhibitor, estradiol-3-O-sufamate (E2MATE), used on human endometrial explants and in a mouse model of endometriosis, has shown some promising results [108].”
BackgroundGibson, D. A., McInnes, K. J., Critchley, H. O. D., & Saunders, P. T. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2140 · Cited by 44 · cited 7×
“We and others have reported that 3β-hydroxysteroid dehydrogenase (3βHSD) is expressed in endometrial stromal cells [13] and that during decidualisation DHEA can be utilised as an androgen precursor yielding both A4 and T via 3βHSD [3,40,41].”
BackgroundInfluentialSelf-citationRegulation of androgen action during establishment of pregnancy
Gibson, D. A., Simitsidellis, I., & Saunders, P. T. K. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0027 · Cited by 42
Self-citationThe Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
Rižner, T. L., Thalhammer, T., & Özvegy-Laczka, C. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00346 · Cited by 40
Intracrine mechanism of estrogen synthesis in breast cancer
Suzuki, T., Moriya, T., Ishida, T., et al. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.09.007 · Cited by 39 · cited 1×
“There has also been a rapid increase in the number of studies considering the role of locally produced (intracrine) steroids in the aetiology of pathologies including cancers of the breast [8,9] and endometrium [10–12], as well as in regulation of fertility [13] and the aetiology of the oestrogen-dependent disorder en…”
BackgroundAndrogens regulate scarless repair of the endometrial “wound” in a mouse model of menstruation
Cousins, F. L., Kirkwood, P. M., Murray, A. A., Collins, F., Gibson, D. A., & Saunders, P. T. K. (2016) · The FASEB Journal · doi:10.1096/fj.201600078r · Cited by 39 · cited 1×
“Studies in mice have also identified a potential role for androgens in endometrial repair at the time of menstruation [62] at a time when peripheral oestrogens are low, which merits further investigation.”
BackgroundSelf-citationLu, M.-L., Huang, Y.-W., & Lin, S.-X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111726200 · Cited by 39 · cited 2×
“during the secretory phase, such as by activating 20α-hydroxyprogesterone to increase bioavailability of P4 [47].”
BackgroundLeo, B. D., Esnal‐Zufiaurre, A., Collins, F., Critchley, H., & Saunders, P. T. K. (2017) · F1000Research · doi:10.12688/f1000research.11432.2 · Cited by 39
Self-citationTanaka, S., Miki, Y., Hashimoto, C., Takagi, K., Doe, Z., Li, B., Yaegashi, N., Suzuki, T., & Ito, K. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.11.022 · Cited by 38 · cited 2×
“They found that women immunonegative for both AR and 5αR1 had a poorer prognosis [87], consistent with other studies that have suggested androgens can be anti-proliferative for EC cells.”
BackgroundResultExpression analysis of estrogen-metabolizing enzymes in human endometrial cancer
Šmuc, T., Rupreht, R. R., Šinkovec, J., Adamski, J., & Rižner, T. L. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.013 · Cited by 36
The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer
Sinreih, M., Knific, T., Anko, M., Hevir, N., Vouk, K., Jerin, A., Frković Grazio, S., & Rižner, T. L. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00368 · Cited by 33
Aromatase cytochrome P450 gene expression in endometrial carcinoma
Sasano, H., Kaga, K., Sato, S., Yajima, A., Nagura, H., & Harada, N. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.586 · Cited by 32 · cited 1×
“Sasano and collaborators have developed novel antibodies and reported evidence of increased immunoexpression of aromatase [81], STS [82] and 17βHSD enzymes [83] in endometrial hyperplasia and EC.”
BackgroundIto, K., Miki, Y., Suzuki, T., McNamara, K. M., & Sasano, H. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-15-0470 · Cited by 29
Das, A., Li, Q., Laws, M. J., Kaya, H., Bagchi, M. K., & Bagchi, I. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297663 · Cited by 29 · cited 1×
“Landmark studies in mice by the Bagchi group demonstrated that aromatase activity within the endometrium was essential for establishment of pregnancy in that species [49,50].”
BackgroundRhee, H. S., Oh, S. H., Ko, B. J., Han, D. M., Jeon, B. H., Park, H., Moon, H. B., & Kim, W. S. (2003) · Experimental & Molecular Medicine · doi:10.1038/emm.2003.22 · Cited by 28 · cited 1×
“We and others have reported that 3β-hydroxysteroid dehydrogenase (3βHSD) is expressed in endometrial stromal cells [13] and that during decidualisation DHEA can be utilised as an androgen precursor yielding both A4 and T via 3βHSD [3,40,41].”
BackgroundERβ-dependent effects on uterine endothelial cells are cell specific and mediated via Sp1
Greaves, E., Collins, F., Critchley, H. O. D., & Saunders, P. T. K. (2013) · Human Reproduction · doi:10.1093/humrep/det235 · Cited by 28 · cited 1×
“Other studies that have highlighted oestrogen-dependent changes in endometrial endothelial cell gene expression [58] that will also be influenced by local (intracrine) metabolism/biosynthesis of bioactive oestrogens.”
BackgroundSelf-citationSalah, M., Abdelsamie, A. S., & Frotscher, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00062 · Cited by 28 · cited 1×
“A dual STS/17βHSD1 inhibitor has been shown to block the proliferation of cancer cells treated with E1S/E1 but not those treated with E2 alone [109], but this awaits further testing in vivo.”
BackgroundKonings, G. F., Cornel, K. M., Xanthoulea, S., Delvoux, B., Skowron, M. A., Kooreman, L., Koskimies, P., Krakstad, C., Salvesen, H. B., van Kuijk, K., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5004 · Cited by 26
Cornel, K. M. C., Krakstad, C., Delvoux, B., Xanthoulea, S., Jori, B., Bongers, M. Y., Konings, G. F. J., Kooreman, L. F. S., Kruitwagen, R. F., Salvesen, H. B., et al. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.030 · Cited by 26 · cited 2×
“High expression of 17βHSD1 is associated with poor prognosis in EC [84].”
BackgroundAre aromatase inhibitors effective in endometriosis treatment?
Colette, S., & Donnez, J. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.581226 · Cited by 26 · cited 1×
“These have been complemented by several studies reporting on the positive impact, or lack thereof, of aromatase inhibitors (AI) including letrozole and anastrozole on symptoms of endometriosis in both pre- and post-menopausal women [99,100].”
BackgroundIn vitro metabolism of C19 steroids in human endometrium
Hausknecht, V., de la Osa, E. L., & Gurpide, E. (1982) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(82)90563-5 · Cited by 18 · cited 2×
“Subsequent more detailed investigations have demonstrated that the endometrium expresses enzymes capable of biosynthesis, as well as metabolism of steroids, with endometrial cells having the capacity to enzymatically convert androgens into oestrogens, as well as to utilise adrenal and sulphated steroid precursors [36].”
BackgroundHickey, M., & Marino, J. L. (2019) · Menopause The Journal of The North American Menopause Society · Cited by 18
Sivik, T., Gunnarsson, C., Fornander, T., Nordenskjöld, B., Skoog, L., Stål, O., & Jansson, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040568 · Cited by 17 · cited 1×
“HSD17B14 also has oxidative 17β-HSD activity and has been immunolocalised to endometrial glandular epithelial cells [46] although relative efficiency for oxidation of E2 or T was much lower than”
BackgroundLabrie, F., & Martel, C. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2016-0042 · Cited by 17 · cited 1×
“They have demonstrated positive impacts on vaginal dryness and other steroid hormone-dependent parameters without any evidence of peripheral changes in serum E2 [94,95].”
BackgroundGibson, D. A., Foster, P. A., Simitsidellis, I., Critchley, H. O. D., Kelepouri, O., Collins, F., & Saunders, P. T. K. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0037 · Cited by 10 · cited 4×
“There is little evidence for expression of DHEA sulphating enzymes/activity in the endometrium, although expression of SULT1A1 and SULT2B1a were reported in endometrial stromal cells together with PAPSS1 and PAPSS2 [48].”
BackgroundInfluentialSelf-citationInflammatory cytokines in peritoneal fluid of women with endometriosis
SKRZYPCZAK, J., JEDRZEJCZAK, P., KASPRZAK, M., PUK, E., & KURPISZ, M. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb32380.x · Cited by 9 · cited 1×
“Peritoneal fluid from women with endometriosis contains high concentrations of pro-inflammatory cytokines, such as TNFα and IL-1β [70,71], which have the capacity to stimulate expression of the prostaglandin synthesis enzyme COX-2 and increase secretion of prostaglandin E2 (PGE2) by endometriotic cells and peritoneal…”
BackgroundLeo, B. D., Esnal-Zufiaurre, A., Collins, F., Critchley, H. O. D., & Saunders, P. T. K. (2017) · F1000Research · doi:10.12688/f1000research.11432.1 · Cited by 7
Self-citationAtlas of Endometrial Histopathology
Dallenbach-Hellweg, G., Schmidt, D., & Dallenbach, F. (2010) · doi:10.1007/978-3-642-01541-0 · Cited by 5
Cited by
Physiology of the Endometrium and Regulation of Menstruation
Critchley, H. O. D., Maybin, J. A., Armstrong, G. M., & Williams, A. R. W. (2020) · Physiological Reviews · doi:10.1152/physrev.00031.2019 · Cited by 536
Uterine bleeding: how understanding endometrial physiology underpins menstrual health
Jain, V., Chodankar, R. R., Maybin, J. A., & Critchley, H. O. D. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00629-4 · Cited by 165
Wiwatpanit, T., Murphy, A. R., Lu, Z., Urbanek, M., Burdette, J. E., Woodruff, T. K., & Kim, J. J. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz100 · Cited by 135
Nola, R. D., Menga, A., Castegna, A., Loizzi, V., Ranieri, G., Cicinelli, E., & Cormio, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102401 · Cited by 103
Analysis of serum and endometrial progesterone in determining endometrial receptivity
Labarta, E., Sebastián-León, P., Devesa-Peiró, A., Celada, P., Vidal, C., Gilés, J., Rodríguez-Varela, C., Bosch, E., & Díaz-Gimeno, P. (2021) · Human Reproduction · doi:10.1093/humrep/deab184 · Cited by 96
Metadata
- Authors
- Gibson, D. A., Simitsidellis, I., Collins, F., & Saunders, P. T. K.
- Affiliations
- Centre for Inflammation Research (GB)
- Corresponding author
- Saunders, Philippa T.K.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-10-22
- Volume
- 19
- Issue
- 10
- Pages
- 3276
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6214123
- OpenAlex
- W2894914503
- Cited by
- 70
- References
- 120
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 10 · 2020: 10 · 2019: 6 · 2018: 1
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Preprints.org (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Medical Research Council (MR/N024524/1, MR/P00265X/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- steroid hormone metabolism, aromatase, estrogen, androgens, endometrium, menstrual cycle, androgen receptor, estrogen synthesis, endometriosis, endometrial cancer, steroid hormone receptors
- MeSH terms
- Androgens, Dehydroepiandrosterone, Endometrium, Estrogens, Female, Humans, Testosterone, Uterine Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.